𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Olpadronate Prevents the Bone Loss Induced by Cyclosporine in the Rat

✍ Scribed by S. Zeni; S. Gregorio; A.C. Gomez; J. Somoza; C. Mautalen

Publisher
Springer
Year
2002
Tongue
English
Weight
140 KB
Volume
70
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevention of bone loss by percutaneous
Prevention of bone loss by percutaneous estradiol implants in ovariectomized rats
✍ Yamamura, Keiko ;Iwata, Hisashi ;Osada, Takashi ;Yano, Kohji ;Yotsuyanagi, Toshi πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 501 KB

This study was conducted to investigate whether hydroxyapatite (HAP) is appropriate as a percutaneous drug carrier for estradiol (E2) for the suppression of bone loss. Tenweek-old female Sprague-Dawley rats were subjected either to bilateral ovariectomy (OVX) or to sham surgery (control). Ovariectom

Inhibition of osteoblastic metalloprotei
Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency
✍ Corinne Schiltz; Caroline Marty; Marie-Christine de Vernejoul; Valerie Geoffroy πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 291 KB

## Abstract Matrix metalloproteinases (MMPs) are key mediators in extra‐cellular matrix remodelling and implicated primarily in bone growth, and particularly in osteoclastic bone resorption. We hypothesise that MMPs have a role in the increased bone remodelling resulting from oestrogen deficiency.